Document Detail

The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.
MedLine Citation:
PMID:  1577228     Owner:  NLM     Status:  MEDLINE    
Ursodeoxycholic acid therapy (600 mg/day) was evaluated in twelve patients with non-advanced chronic cholestasis. Within four months, ursodeoxycholic acid replaced more than 50% of total bile acids in 8 patients and the reduction of serum gamma-glutamyltranspeptidase, alkaline phosphatase and transaminases averaged 30% or more. The serum levels of chenodeoxycholic acid depend on those of ursodeoxycholic acid, but are not related to those of biochemical parameters. Drug therapy was continued in three poor responders for 2-3 four-month periods. In one case an increase of the serum proportion of ursodeoxycholic acid was associated with a reduction in biochemical parameters. The other two cases had high serum levels of chenodeoxycholic acid and/or cholic acid throughout the entire course of treatment. While the treatment of chronic cholestasis requires an effectual serum proportion of ursodeoxycholic acid, it is important to distinguish endogenous persistent hyper-bile-acidemia from ursodeoxycholic acid-related acidemia.
T Higuchi; N Hishida; T Isomura; H Takeshima; H Hayashi
Related Documents :
12526048 - Association of amino acid substitution pattern in nonstructural protein 5a of hepatitis...
17098598 - Budesonide combined with ursodeoxycholic acid in primary biliary cirrhosis with advance...
2347548 - The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the ra...
14685078 - Efficacy and safety measurements of proton pump inhibitors in infants and children.
21912728 - Sensitive detection of nucleic acids by pna hybridization directed co-localization of f...
25233258 - Design, synthesis, 3d pharmacophore, qsar, and docking studies of carboxylic acid deriv...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Gastroenterologia Japonica     Volume:  27     ISSN:  0435-1339     ISO Abbreviation:  Gastroenterol. Jpn.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-06-05     Completed Date:  1992-06-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0152744     Medline TA:  Gastroenterol Jpn     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  222-9     Citation Subset:  IM    
Third Department of Medicine, Nagoya University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bile Acids and Salts / blood*
Cholangitis, Sclerosing / complications,  drug therapy*
Cholestasis / drug therapy,  etiology
Liver Cirrhosis, Biliary / complications,  drug therapy*
Liver Function Tests
Middle Aged
Ursodeoxycholic Acid / administration & dosage,  therapeutic use*
Reg. No./Substance:
0/Bile Acids and Salts; 128-13-2/Ursodeoxycholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pathogenesis of hepatic atrophy in canine model of hepatolithiasis.
Next Document:  Unusual rapidly growing gastric myxoid neurofibroma: a case report.